| Dr Anthony G Visco, MD | |
|
101 Manning Dr, Chapel Hill, NC 27599-0001 | |
| (919) 966-4996 | |
| (919) 843-5515 |
| Full Name | Dr Anthony G Visco |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 31 Years |
| Location | 101 Manning Dr, Chapel Hill, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144318445 | NPI | - | NPPES |
| 891058M | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 9701185 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Duke University Hospital | Durham, NC | Hospital |
| Duke Health Raleigh Hospital | Raleigh, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Duke Health Integrated Practice Inc | 8325412737 | 2551 |
News Archive
AVAC today issues a call to action to donors, policy-makers, researchers and advocates to ensure that critical follow-up studies to the landmark CAPRISA 004 microbicide trial receive the economic and political support needed to move forward as quickly as possible. The call comes as a group of microbicide and public health experts have agreed upon a plan for further studies, which are expected to cost $100 million over three years, of which only $58 million has been committed.
In a study spanning molecular genetics, stem cells and the sciences of both brain and behavior, researchers at University of California San Diego, with colleagues at the Salk Institute for Biological Studies and elsewhere, have created a neurodevelopmental model of a rare genetic disorder that may provide new insights into the underlying neurobiology of the human social brain.
LEO Pharma is in dialogue with the Greek authorities to find an alternative solution to withdrawing the company's pharmaceutical products from the Greek market.
A study conducted by researchers in the UK has found that people who think they have had COVID-19 are more likely to believe they are immune to the infection and less likely to follow social distancing rules.
The New York Times: "Telemedicine has the potential to improve quality of care by allowing clinicians in one 'control center' to monitor, consult and even care for and perform procedures on patients in multiple locations," Doctor and Patient columnist Pauline Chen writes. "A rural primary care practitioner who sees a patient with a rare skin lesion, for example, can get expert consultation from a dermatologist at a center hundreds of miles away."
› Verified 7 days ago
| Entity Name | Private Diagnostic Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457389033 PECOS PAC ID: 1355254368 Enrollment ID: O20031204000577 |
News Archive
AVAC today issues a call to action to donors, policy-makers, researchers and advocates to ensure that critical follow-up studies to the landmark CAPRISA 004 microbicide trial receive the economic and political support needed to move forward as quickly as possible. The call comes as a group of microbicide and public health experts have agreed upon a plan for further studies, which are expected to cost $100 million over three years, of which only $58 million has been committed.
In a study spanning molecular genetics, stem cells and the sciences of both brain and behavior, researchers at University of California San Diego, with colleagues at the Salk Institute for Biological Studies and elsewhere, have created a neurodevelopmental model of a rare genetic disorder that may provide new insights into the underlying neurobiology of the human social brain.
LEO Pharma is in dialogue with the Greek authorities to find an alternative solution to withdrawing the company's pharmaceutical products from the Greek market.
A study conducted by researchers in the UK has found that people who think they have had COVID-19 are more likely to believe they are immune to the infection and less likely to follow social distancing rules.
The New York Times: "Telemedicine has the potential to improve quality of care by allowing clinicians in one 'control center' to monitor, consult and even care for and perform procedures on patients in multiple locations," Doctor and Patient columnist Pauline Chen writes. "A rural primary care practitioner who sees a patient with a rare skin lesion, for example, can get expert consultation from a dermatologist at a center hundreds of miles away."
› Verified 7 days ago
| Entity Name | Duke Health Integrated Practice Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205553369 PECOS PAC ID: 8325412737 Enrollment ID: O20230327002247 |
News Archive
AVAC today issues a call to action to donors, policy-makers, researchers and advocates to ensure that critical follow-up studies to the landmark CAPRISA 004 microbicide trial receive the economic and political support needed to move forward as quickly as possible. The call comes as a group of microbicide and public health experts have agreed upon a plan for further studies, which are expected to cost $100 million over three years, of which only $58 million has been committed.
In a study spanning molecular genetics, stem cells and the sciences of both brain and behavior, researchers at University of California San Diego, with colleagues at the Salk Institute for Biological Studies and elsewhere, have created a neurodevelopmental model of a rare genetic disorder that may provide new insights into the underlying neurobiology of the human social brain.
LEO Pharma is in dialogue with the Greek authorities to find an alternative solution to withdrawing the company's pharmaceutical products from the Greek market.
A study conducted by researchers in the UK has found that people who think they have had COVID-19 are more likely to believe they are immune to the infection and less likely to follow social distancing rules.
The New York Times: "Telemedicine has the potential to improve quality of care by allowing clinicians in one 'control center' to monitor, consult and even care for and perform procedures on patients in multiple locations," Doctor and Patient columnist Pauline Chen writes. "A rural primary care practitioner who sees a patient with a rare skin lesion, for example, can get expert consultation from a dermatologist at a center hundreds of miles away."
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anthony G Visco, MD 143 W Franklin St, Chapel Hill, NC 27516-2539 Ph: (919) 966-4996 | Dr Anthony G Visco, MD 101 Manning Dr, Chapel Hill, NC 27599-0001 Ph: (919) 966-4996 |
News Archive
AVAC today issues a call to action to donors, policy-makers, researchers and advocates to ensure that critical follow-up studies to the landmark CAPRISA 004 microbicide trial receive the economic and political support needed to move forward as quickly as possible. The call comes as a group of microbicide and public health experts have agreed upon a plan for further studies, which are expected to cost $100 million over three years, of which only $58 million has been committed.
In a study spanning molecular genetics, stem cells and the sciences of both brain and behavior, researchers at University of California San Diego, with colleagues at the Salk Institute for Biological Studies and elsewhere, have created a neurodevelopmental model of a rare genetic disorder that may provide new insights into the underlying neurobiology of the human social brain.
LEO Pharma is in dialogue with the Greek authorities to find an alternative solution to withdrawing the company's pharmaceutical products from the Greek market.
A study conducted by researchers in the UK has found that people who think they have had COVID-19 are more likely to believe they are immune to the infection and less likely to follow social distancing rules.
The New York Times: "Telemedicine has the potential to improve quality of care by allowing clinicians in one 'control center' to monitor, consult and even care for and perform procedures on patients in multiple locations," Doctor and Patient columnist Pauline Chen writes. "A rural primary care practitioner who sees a patient with a rare skin lesion, for example, can get expert consultation from a dermatologist at a center hundreds of miles away."
› Verified 7 days ago
George Nowacek, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Manning Dr, Chapel Hill, NC 27599 Phone: 919-843-7851 Fax: 540-368-5206 | |
Christine Mirng-en Chu, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Manning Dr, Chapel Hill, NC 27514 Phone: 919-966-5283 | |
Dr. Mary Elizabeth Schlegel, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: University Of North Carolina Campus Health Service, Cb # 7470, Chapel Hill, NC 27599 Phone: 919-843-6301 Fax: 919-966-6356 | |
Dr. Stuart-allison Moffat Staley, MD, MPH Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Manning Dr, Department Of Ob/gyn, Chapel Hill, NC 27514 Phone: 919-966-6823 Fax: 919-966-6356 | |
Lauren Nord Tholemeier, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 101 Manning Dr, Chapel Hill, NC 27514 Phone: 984-974-1000 | |
Dr. Linda Van Le, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Manning Dr, Chapel Hill, NC 27599 Phone: 919-966-4996 Fax: 919-843-5515 | |
Erica Lynn O'neill, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 Manning Dr, Unc Hospitals, Chapel Hill, NC 27514 Phone: 919-843-6301 Fax: 919-966-6356 |